(a) Studying issues related to the prescription monitoring program established under ORS 431A.855;
(b) Reviewing the program’s annual report and making recommendations to the Oregon Health Authority regarding the operation of the program; and
(c) Developing criteria used to evaluate program data.
(2) The commission shall consist of 11 members appointed by the authority as follows:
(a) A person nominated by the Pain Management Commission;
(b) A person who dispenses controlled substances nominated by an association representing pharmacists;
(c) A practicing dentist nominated by an association representing dentists;
(d) A practicing doctor of medicine nominated by an association representing doctors of medicine;
(e) A practicing doctor of osteopathic medicine nominated by an association representing osteopathic physicians and surgeons;
(f) A nurse authorized to prescribe controlled substances nominated by an association representing nurses;
(g) A practicing naturopathic physician nominated by an association representing naturopathic physicians;
(h) A practicing optometrist, nominated by an association representing optometrists;
(i) A representative of the authority with expertise in administering addiction services; and
(j) Two members of the public, one of whom must be an expert in information technology. [Formerly 431.976; 2017 c.409 §13]